Literature DB >> 9401315

Effective treatment of mania with olanzapine: 2 case reports.

A V Ravindran, B W Jones, K al-Zaid, Y D Lapierre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401315      PMCID: PMC1188885     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  5 in total

1.  Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial.

Authors:  C M Beasley; T Sanger; W Satterlee; G Tollefson; P Tran; S Hamilton
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophrenia.

Authors:  D S Baldwin; S A Montgomery
Journal:  Int Clin Psychopharmacol       Date:  1995-11       Impact factor: 1.659

3.  Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

Authors:  G D Tollefson; C M Beasley; P V Tran; J S Street; J A Krueger; R N Tamura; K A Graffeo; M E Thieme
Journal:  Am J Psychiatry       Date:  1997-04       Impact factor: 18.112

4.  Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.

Authors:  C M Beasley; G Tollefson; P Tran; W Satterlee; T Sanger; S Hamilton
Journal:  Neuropsychopharmacology       Date:  1996-02       Impact factor: 7.853

5.  Carbamazepine compared to haloperidol in acute mania.

Authors:  D Brown; T Silverstone; J Cookson
Journal:  Int Clin Psychopharmacol       Date:  1989-07       Impact factor: 1.659

  5 in total
  6 in total

1.  Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment.

Authors:  P Pozo; A G Alcántara
Journal:  J Psychiatry Neurosci       Date:  1998-11       Impact factor: 6.186

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 3.  Olanzapine: a review of its use in the treatment of bipolar I disorder.

Authors:  N Bhana; C M Perry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 4.  Atypical antipsychotics and mood stabilization in bipolar disorder.

Authors:  Paolo Brambilla; Francesco Barale; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

5.  Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009.

Authors:  Joseph Hayes; Philip Prah; Irwin Nazareth; Michael King; Kate Walters; Irene Petersen; David Osborn
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

6.  Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy.

Authors:  Gioia Baggiani; Luca Ambrosiani; Pierfranco Trincas; Caterina Burrai; Alberto Bocchetta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2018-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.